loading

Milestone Pharmaceuticals Inc Aktie (MIST) Neueste Nachrichten

pulisher
Nov 21, 2025

Milestone Pharmaceuticals Inc. (MIST) stock price, news, quote and history - Yahoo Finance UK

Nov 21, 2025
pulisher
Nov 21, 2025

Milestone Pharmaceuticals Inc. (MIST) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 21, 2025
pulisher
Nov 21, 2025

Is Milestone Pharmaceuticals Inc. stock bottoming outJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How analysts rate Milestone Pharmaceuticals Inc. stock today2025 Market Trends & Daily Oversold Bounce Ideas - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Published on: 2025-11-20 02:01:48 - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Can Milestone Pharmaceuticals Inc. recover in the next quarter2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 17:33:54 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why analysts remain bullish on Milestone Pharmaceuticals Inc. stockJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 13:39:11 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 06:17:41 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Using Bollinger Bands to evaluate Milestone Pharmaceuticals Inc.Weekly Volume Report & AI Powered Market Entry Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Milestone Pharmaceuticals Inc. stock reacts to oil pricesTreasury Yields & Daily Market Momentum Tracking - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

How to forecast Milestone Pharmaceuticals Inc. trends using time series2025 Year in Review & Stock Portfolio Risk Control - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Shares Could Be 44% Below Their Intrinsic Value Estimate - Yahoo Finance

Nov 18, 2025
pulisher
Nov 16, 2025

Will Milestone Pharmaceuticals Inc. stock remain a Wall Street favorite2025 Volume Leaders & Weekly Momentum Picks - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Can Milestone Pharmaceuticals Inc. stock resist sector downturns2025 Price Momentum & Expert Approved Trade Ideas - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Is it too late to sell Milestone Pharmaceuticals Inc.Weekly Stock Report & Safe Swing Trade Setups - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Does Milestone Pharmaceuticals (NASDAQ:MIST) Have A Healthy Balance Sheet? - simplywall.st

Nov 15, 2025
pulisher
Nov 14, 2025

Combining price and volume data for Milestone Pharmaceuticals Inc.Trade Risk Report & Capital Efficiency Focused Ideas - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Will Milestone Pharmaceuticals Inc. stock benefit from commodity pricesTrade Risk Summary & Weekly Top Performers Watchlists - Fundação Cultural do Pará

Nov 14, 2025
pulisher
Nov 13, 2025

Jefferies raises Milestone Pharmaceuticals stock price target to $2 from $1 - Investing.com Canada

Nov 13, 2025
pulisher
Nov 13, 2025

What the charts say about Milestone Pharmaceuticals Inc. todayWeekly Gains Summary & Daily Chart Pattern Signals - newser.com

Nov 13, 2025
pulisher
Nov 12, 2025

Milestone Pharmaceuticals Reports Q3 2025 Financial Results - TipRanks

Nov 12, 2025
pulisher
Nov 12, 2025

Milestone Pharmaceuticals: Q3 Earnings Snapshot - Norwalk Hour

Nov 12, 2025
pulisher
Nov 12, 2025

Milestone Pharma Q3 net loss widens on commercial expenses - MarketScreener

Nov 12, 2025
pulisher
Nov 12, 2025

Milestone Pharmaceuticals Announces PDUFA Target Date for CARDAMYST™ Nasal Spray as December 13, 2025, with Promotional Launch Plans in Place - Quiver Quantitative

Nov 12, 2025
pulisher
Nov 12, 2025

Milestone Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Regulatory and Corporate Update - The Manila Times

Nov 12, 2025
pulisher
Nov 12, 2025

Milestone Pharmaceuticals Reports Third Quarter 2025 - GlobeNewswire

Nov 12, 2025
pulisher
Nov 12, 2025

Milestone Pharma (Nasdaq: MIST) has Dec 13 PDUFA target for CARDAMYST in PSVT; launch plans set - Stock Titan

Nov 12, 2025
$39.38
price up icon 1.23%
$30.73
price up icon 0.94%
$105.58
price up icon 3.48%
$97.44
price up icon 2.07%
biotechnology ONC
$328.53
price down icon 5.82%
$204.72
price up icon 2.97%
Kapitalisierung:     |  Volumen (24h):